Promoter-Specific Hypomethylation Correlates with IL-1β Overexpression in Tuberous Sclerosis Complex (TSC)

[1]  E. Aronica,et al.  Expression of microRNAs miR21, miR146a, and miR155 in tuberous sclerosis complex cortical tubers and their regulation in human astrocytes and SEGA‐derived cell cultures , 2016, Glia.

[2]  N. Rensing,et al.  Inflammatory mechanisms contribute to the neurological manifestations of tuberous sclerosis complex , 2015, Neurobiology of Disease.

[3]  P. J. Vries,et al.  Neurological and neuropsychiatric aspects of tuberous sclerosis complex , 2015, The Lancet Neurology.

[4]  P. V. van Rijen,et al.  Differential expression and clinical significance of three inflammation-related microRNAs in gangliogliomas , 2015, Journal of Neuroinflammation.

[5]  Jue-qian Zhou,et al.  Effects of Antiepileptic Drug Monotherapy on One-Carbon Metabolism and DNA Methylation in Patients with Epilepsy , 2015, PloS one.

[6]  A. Fuso,et al.  Disclosing Bias in Bisulfite Assay: MethPrimers Underestimate High DNA Methylation , 2015, PloS one.

[7]  G. Coppola,et al.  SIRT1 Deficiency in Microglia Contributes to Cognitive Decline in Aging and Neurodegeneration via Epigenetic Regulation of IL-1β , 2015, The Journal of Neuroscience.

[8]  Ayako Ochi,et al.  Interictal high frequency oscillations correlating with seizure outcome in patients with widespread epileptic networks in tuberous sclerosis complex , 2014, Epilepsia.

[9]  M. Sitges,et al.  The anti‐seizure drugs vinpocetine and carbamazepine, but not valproic acid, reduce inflammatory IL‐1β and TNF‐α expression in rat hippocampus , 2014, Journal of neurochemistry.

[10]  Y. Ben-Ari,et al.  Selective suppression of excessive GluN2C expression rescues early epilepsy in a tuberous sclerosis murine model , 2014, Nature Communications.

[11]  J. Zierath,et al.  Altered promoter methylation of PDK4, IL1 B, IL6, and TNF after Roux-en Y gastric bypass. , 2014, Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery.

[12]  G. Cheng,et al.  MicroRNAs: New Regulators of Toll-Like Receptor Signalling Pathways , 2014, BioMed research international.

[13]  E. Aronica,et al.  Epilepsy Related to Developmental Tumors and Malformations of Cortical Development , 2014, Neurotherapeutics.

[14]  Nils Z. Borgesius,et al.  TORC1‐dependent epilepsy caused by acute biallelic Tsc1 deletion in adult mice , 2013, Annals of neurology.

[15]  E. Aronica,et al.  Epilepsy and brain inflammation , 2013, Experimental Neurology.

[16]  H. Roach,et al.  Regulated Transcription of Human Matrix Metalloproteinase 13 (MMP13) and Interleukin-1β (IL1B) Genes in Chondrocytes Depends on Methylation of Specific Proximal Promoter CpG Sites* , 2013, The Journal of Biological Chemistry.

[17]  S. Zienolddiny,et al.  DNA methylation at promoter regions of interleukin 1B, interleukin 6, and interleukin 8 in non-small cell lung cancer , 2013, Cancer Immunology, Immunotherapy.

[18]  E. Aronica,et al.  Fetal Brain Lesions in Tuberous Sclerosis Complex: TORC1 Activation and Inflammation , 2013, Brain pathology.

[19]  Eleonora Aronica,et al.  Cytoarchitectural alterations are widespread in cerebral cortex in tuberous sclerosis complex , 2012, Acta Neuropathologica.

[20]  N. D’Silva,et al.  Control of Cytokine mRNA Expression by RNA-binding Proteins and microRNAs , 2012, Journal of dental research.

[21]  I. Morita,et al.  The involvement of DNA and histone methylation in the repression of IL-1β-induced MCP-1 production by hypoxia. , 2011, Biochemical and biophysical research communications.

[22]  Susan R. Quinn,et al.  A trio of microRNAs that control Toll-like receptor signalling. , 2011, International immunology.

[23]  P. V. van Rijen,et al.  Activation of Toll-like receptor, RAGE and HMGB1 signalling in malformations of cortical development. , 2011, Brain : a journal of neurology.

[24]  L. O’Neill,et al.  MicroRNAs: the fine-tuners of Toll-like receptor signalling , 2011, Nature Reviews Immunology.

[25]  P. V. van Rijen,et al.  Gene Expression Analysis of Tuberous Sclerosis Complex Cortical Tubers Reveals Increased Expression of Adhesion and Inflammatory Factors , 2009, Brain pathology.

[26]  A. Moorman,et al.  Amplification efficiency: linking baseline and bias in the analysis of quantitative PCR data , 2009, Nucleic acids research.

[27]  E. Aronica,et al.  Inflammatory processes in cortical tubers and subependymal giant cell tumors of tuberous sclerosis complex , 2008, Epilepsy Research.

[28]  D. Brough,et al.  Mechanisms of regulation for interleukin-1β in neurodegenerative disease , 2007, Neuropharmacology.

[29]  E. Aronica,et al.  The IL-1β system in epilepsy-associated malformations of cortical development , 2006, Neurobiology of Disease.

[30]  A. Moorman,et al.  Assumption-free analysis of quantitative real-time polymerase chain reaction (PCR) data , 2003, Neuroscience Letters.

[31]  F. Chiarelli,et al.  Effect of anticonvulsant drugs on interleukins-1, -2 and -6 and monocyte chemoattractant protein-1 , 2001, Clinical and Experimental Medicine.

[32]  D. Swaab,et al.  IL-1β immunoreactive neurons in the human hypothalamus: reduced numbers in multiple sclerosis , 2000, Journal of Neuroimmunology.

[33]  M. Hasegawa,et al.  Expression of lnterleukin-1 β mRNA and Protein in Human Gliomas Assessed by RT-PCR and Immunohistochemistry , 1998, Journal of neuropathology and experimental neurology.

[34]  A. C. Webb,et al.  Interleukin-1: a gene expression system regulated at multiple levels. , 1994, European cytokine network.

[35]  M. Fenton.  Review: transcriptional and post-transcriptional regulation of interleukin 1 gene expression. , 1992, International journal of immunopharmacology.

[36]  Li Zhang,et al.  Negative regulation of inflammation by SIRT1. , 2013, Pharmacological research.

[37]  E. Melloni,et al.  3 – Selective Pro-Inflammatory Activation of Astrocytes by High Mobility Group Box 1 Protein Signaling , 2010 .

[38]  B. Giometto,et al.  Immune infiltrates and cytokines in gliomas , 2005, Acta Neurochirurgica.